BNP Paribas’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
BNP Paribas's LLY Position: Q2 2026 in Review
BNP Paribas increased its Eli Lilly (LLY) stake by 4.4% in Q2 2026, buying an estimated $1.64M and bringing the position to 38,251 shares worth $45.8M. The position accounts for 1.24% of the portfolio, ranked #21.
BNP Paribas first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- BNP Paribas held 38,251 shares of Eli Lilly worth $45.8M as of Q2 2026.
- BNP Paribas bought 1,608 Eli Lilly shares in Q2 2026, an estimated $1.64M.
- Eli Lilly made up 1.24% of BNP Paribas's portfolio in Q2 2026, its #21 holding.
- BNP Paribas first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.